Philippines Pharmaceuticals and Healthcare Report Q4 2014

Date: September 24, 2014
Pages: 132
Price:
US$ 1,295.00
Publisher: Business Monitor International
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P73973A1DC4EN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: The Philippine government's aim to lower pharmaceutical expenditure through medicine price cuts, parallel imports and the use of generic drugs will continue to hinder multinational pharmaceutical firms' investment and interest in the country's pharmaceutical market. Nevertheless, the government's intention to improve healthcare through the implementation of a universal healthcare scheme will continue to present significant revenue-generating opportunities for firms over the long term.

Headline Expenditure Projections
  • Pharmaceuticals: PHP140.20bn (USD3.25bn) in 2013, rising to PHP145.05bn (USD3.30bn) in 2014; +3.5% in local currency terms and +1.6% in US dollar terms.
  • Healthcare: PHP545.09bn (USD12.62bn) in 2013, rising to PHP613.05bn (USD13.93bn) in 2014; +12.5% in local currency terms and +10.4% in US dollar terms.
BMI Industry View
SWOT
Political
Economic
Business Environment
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Philippines 2010-2018)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2010-2018)
  Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2010-2018)
  Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2010-2018)
Philippines
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Philippines 2010-2018)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Philippines 2010-2018)
Generic Drug Market Forecast
  Table: Generic Drug Market Indicators, Historical Data And Forecasts (Philippines 2010-2018)
OTC Medicine Market Forecast
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Philippines 2010-2018)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecasts (Philippines 2012-2018)
  Table: Pharmaceutical Trade Data And Forecasts local currency (Philippines 2012-2018)
Other Healthcare Data
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Investment To Continue Its Charge
Likely Recovery In The Export Sector
Typhoon Yolanda To Spur Public Spending
Remittances Supporting Private Consumption Growth
Risks To Economic Outlook
  Table: Philippines - Economic Activity
Industry Risk Reward Ratings
Asia Pacific Risk/Reward Ratings
Philippines Risk/Reward Ratings
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Health Insurance
Healthcare Sector Financing
Medical Tourism
Biotechnology And Research
Traditional Medicines
Clinical Trials
Regulatory Development
  Table: History Of Food And Drugs Administration
Intellectual Property Regime
Pricing Regime
  Table: Medicines Subject To March 31 2010 Government Mediated Access Price
Reimbursement Regime
International Cooperation
Competitive Landscape
Pharmaceutical Industry
  Table: Pharmaceutical Industry Overview
Domestic Pharmaceutical Industry
Pharmaceutical Distribution and Retail
  Table: Overview Of BnB, BNB and P100 Programme
  Table: Cost Of Generic Drugs In Philippines (PHP)
  Table: Number Of BnBs And BNBs In Selected Philippine Regions
Company Profile
Unilab
Pascual Laboratories
Pacific Pharmaceutical Generics
MediChem Pharmaceuticals
GlaxoSmithKline Philippines
Pfizer
Novartis
Merck & Co
Sanofi
Demographic Forecast
Demographic Outlook
  Table: The Philippines' Population By Age Group, 1990-2020 ('000)
  Table: The Philippines' Population By Age Group, 1990-2020 (% of total)
  Table: The Philippines' Key Population Ratios, 1990-2020
  Table: The Philippines' Rural And Urban Population, 1990-2020
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Ratings Methodology
Ratings Overview
  Table: Pharmaceutical Risk/Reward Ratings Indicators
Indicator Weightings

Ask Your Question

Philippines Pharmaceuticals and Healthcare Report Q4 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: